Your browser doesn't support javascript.
loading
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease.
Brown, Emmeline E; Blauwendraat, Cornelis; Trinh, Joanne; Rizig, Mie; Nalls, Mike A; Leveille, Etienne; Ruskey, Jennifer A; Jonvik, Hallgeir; Tan, Manuela M X; Bandres-Ciga, Sara; Hassin-Baer, Sharon; Brockmann, Kathrin; Infante, Jon; Tolosa, Eduardo; Ezquerra, Mario; Ben Romdhan, Sawssan; Benmahdjoub, Mustapha; Arezki, Mohamed; Mhiri, Chokri; Hardy, John; Singleton, Andrew B; Alcalay, Roy N; Gasser, Thomas; Grosset, Donald G; Williams, Nigel M; Pittman, Alan; Gan-Or, Ziv; Fernandez-Santiago, Ruben; Brice, Alexis; Lesage, Suzanne; Farrer, Matthew; Wood, Nicholas; Morris, Huw R.
Afiliação
  • Brown EE; Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, UK.
  • Blauwendraat C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Trinh J; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Rizig M; Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, UK.
  • Nalls MA; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA; Data Tecnica International, Glen Echo, MD, USA.
  • Leveille E; Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada.
  • Ruskey JA; Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada.
  • Jonvik H; Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, UK.
  • Tan MMX; Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, UK.
  • Bandres-Ciga S; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
  • Hassin-Baer S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Neurology, Sheba Medical Center, Tel HaShomer, Israel; Movement Disorders Institute, Sheba Medical Center, Tel HaShomer, Israel.
  • Brockmann K; Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University Clinic Tu¨bingen, Tu¨bingen, Germany.
  • Infante J; Service of Neurology, University Hospital "Marqués de Valdecilla (IDIVAL)", University of Cantabria; "Centro de Investigación Biomédica en Red de Enfermedades, Neurodegenerativas (CIBERNED)", Santander, Spain.
  • Tolosa E; Laboratory of Parkinson Disease & Other Neurodegenerative Movement Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - Hospital Clínic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED: CB06/05/001
  • Ezquerra M; Laboratory of Parkinson Disease & Other Neurodegenerative Movement Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - Hospital Clínic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED: CB06/05/001
  • Ben Romdhan S; Research Unit in Neurogenetics, Clinical Investigation Center (CIC) at the CHU Habib Bourguiba, Sfax, Tunisia.
  • Benmahdjoub M; Frantz Fanon Hospital, CHU Blida, Blida, Algeria.
  • Arezki M; Frantz Fanon Hospital, CHU Blida, Blida, Algeria.
  • Mhiri C; Frantz Fanon Hospital, CHU Blida, Blida, Algeria.
  • Hardy J; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK; UK Dementia Research Institute at UCL and Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK; Reta Lila Weston Institute, UCL Q
  • Singleton AB; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Alcalay RN; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.
  • Gasser T; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tu¨bingen, Tu¨bingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tu¨bingen, Germany.
  • Grosset DG; Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK; Institute of Neuroscience & Psychology, University of Glasgow, Glasgow, UK.
  • Williams NM; Division of Psychological Medicine & Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, UK.
  • Pittman A; Department of Clinical Genetics, St George's, University of London, London, UK.
  • Gan-Or Z; Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Fernandez-Santiago R; Laboratory of Parkinson Disease & Other Neurodegenerative Movement Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - Hospital Clínic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED: CB06/05/001
  • Brice A; Research Unit U1127 at INSERM, Research Unit UMR 7225 at the French National Centre for Scientific Research (CNRS) Research Unit UMR_1127 at Sorbonne Université, Institutet du Cerveau et de la Moëlle épinière (ICM), Paris, France.
  • Lesage S; Research Unit U1127 at INSERM, Research Unit UMR 7225 at the French National Centre for Scientific Research (CNRS) Research Unit UMR_1127 at Sorbonne Université, Institutet du Cerveau et de la Moëlle épinière (ICM), Paris, France.
  • Farrer M; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Wood N; Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, UK.
  • Morris HR; Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, UK. Electronic address: h.morris@ucl.ac.uk.
Neurobiol Aging ; 97: 148.e17-148.e24, 2021 01.
Article em En | MEDLINE | ID: mdl-32873436
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Variação Genética / Predisposição Genética para Doença / Dinamina III / Proteínas R-SNARE / Estudos de Associação Genética / Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurobiol Aging Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Variação Genética / Predisposição Genética para Doença / Dinamina III / Proteínas R-SNARE / Estudos de Associação Genética / Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurobiol Aging Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos